Previous investigations on Madin Darby Canine Kidney (MDCK) cells demo
nstrated the protective effect of verapamil against shockwave-induced
tubular dysfunction. In the present study, we investigated whether ver
apamil is also protective against shockwave-induced damage in vivo. Ma
le rates were randomly assigned to three groups: verapamil (N = 18) (G
roup I), control (N = 18) (Group II), or sham treatment (N = 4) (Group
III). Groups I and II were treated with 500 shockwaves to each kidney
with the Dornier MFL 5000 at 18 kV. Animals assigned to Group III rec
eived only anesthesics. Verapamil was given to the animals in Group I
for 5 days starting 1 day before shockwave exposure. Urine was collect
ed for 8 hours the day before and immediately, 1.7, and 28 days after
shockwave exposure (SWE) for measurement of volume, osmolality, hemogl
obin, protein, N-acetyl-beta-glucosaminidase (NAG), beta2-microglobuli
n (beta2M), sodium, and creatinine. Kidneys were perfused and removed
for histologic study 1,7, and 28 days after SWE in six animals of Grou
ps I and II. Blood was taken in these rats (Day 1 after SWE) for the d
etermination of creatinine and sodium and the calculation of the creat
inine clearance (CCr) and the fractional excretion of sodium (FENa). A
fter SWE, there was strong diuresis and significantly increased excret
ion of NAG and beta2M in the controls, while urine osmolality decrease
d. These changes were significantly less pronounced in the verapamil-t
reated rats. The CCr was higher and FENa lower than in the latter grou
p. Histologic study demonstrated dilation of the intrarenal veins and
tubules and swelling, vacuolization, and potocytosis of the epithelial
cells. These alterations were more pronounced in the control animals
than in the verapamil-treated rats. No changes were observed in the sh
am-treated group. The biochemical and histologic results demonstrate t
hat verapamil was able to ameliorate the damaging effects of high-ener
gy shockwaves on renal tissue not only in vitro, but also in vivo.